Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-598-3 | CAS number: 7647-14-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- other: publication
- Adequacy of study:
- key study
- Study period:
- 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Sufficient information is available for the interpretation of results.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Acute cytogenetic effects of tyramine, MTCAs, NaCl and soy sauce on rat bone marrow cells in vivo
- Author:
- Fujie et al.
- Year:
- 1 989
- Bibliographic source:
- published in Mutation Research, 240 (1990) 281-288
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- not specified
- Principles of method if other than guideline:
- none
- GLP compliance:
- not specified
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Sodium chloride
- EC Number:
- 231-598-3
- EC Name:
- Sodium chloride
- Cas Number:
- 7647-14-5
- Molecular formula:
- ClNa
- IUPAC Name:
- sodium chloride
- Reference substance name:
- 231-589-3
- IUPAC Name:
- 231-589-3
- Details on test material:
- - Name of test material (as cited in study report): Sodium Chloride
- Molecular formula (if other than submission substance): NaCl
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Long-Evans
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Long-Evans rats outbred from the colony of the Ben May Laboratory for Cancer Research, University of Chicago)
- Age at study initiation: aged 4-6 weeks
- Weight at study initiation: 50-100 g
- Assigned to test groups randomly: [no/yes, under following basis: ]
- Fasting period before study: not specified in the report
- Housing:not specified in the report
- Diet (e.g. ad libitum): They were fed a commercial ration of NMF (Oriental Ferment Co., Tokyo)
- Water (e.g. ad libitum): water ad libitum
- Acclimation period: not specified in the report
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ° C.
- Humidity (%):not specified in the report
- Air changes (per hr):not specified in the report
- Photoperiod (hrs dark / hrs light):not specified in the report
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: physiological saline.
- Concentration of test material in vehicle: 10-40 mmole/kg (584.4-2338 mg/kg) of NaCl dissolved in physiological saline. - Details on exposure:
- not applicable
- Duration of treatment / exposure:
- Dose-response relationships were studied in cells sampled 6 h after intraperitoneal administration of various amounts of NaCl. The time course of
aberrant cells was examined 3, 6, 12, 18 and 24 h after treatment with 40 mmole/kg (2338 mg/kg) of NaC1. The percentage of aberrant cells
reached a maximum level after 6 h. - Frequency of treatment:
- not specified in the report
- Post exposure period:
- The time course of aberrant cells was examined 3, 6, 12, 18 and 24 h after treatment with 40 mmole/kg (2338 mg/kg)
of NaC1. The percentage of aberrant cells reached a maximum level after 6 h.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
10 mmole/kg
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
20 mmole/kg
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
40 mmole/kg
Basis:
nominal conc.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- not specified in the report
Examinations
- Tissues and cell types examined:
- Bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Not specified in the report.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): The time course of aberrant cells was examined 3, 6, 12, 18 and 24 h after treatment with 40 mmole/kg (2338 mg/kg) of NaC1. The percentage of aberrant cells reached a maximum level after 6 h with 40 mmole/kg (2338 mg/kg) of NaCl.
DETAILS OF SLIDE PREPARATION: Chromosome specimens were prepared from the femur bone marrow by the conventional
method (Sugiyama, 1971), stained in 2% Giemsa solution (pH 6.8) for 15 rain, and analyzed microscopically under blind code.
METHOD OF ANALYSIS: Chromosome aberrations (CA) defining aberrant metaphase cells consisted of breaks and gaps, and all breaks were of the chromatid type. Gaps were defined by a clear achromatic lesion with chromatid continuity, and breaks by discontinuity. Cells with gaps did not include in the category of damaged cells, based on the general opinion (Adler et al., 1971; Legator et al., 1973) that gaps are not a good indicator of chromosome damage. About 150-200 metaphase cells were examined per rat and the percent aberrant metaphase cells was calculated.
Each group consisted of 5 rats. Positive results were defined by significant differences in the X 2- test. - Evaluation criteria:
- There are several criteria for determining a positive result, such as a dose-related increase in the relative number of cells with chromosome aberrations or a clear increase in the number of cells with aberrations in a single dose group at a single sampling time. Biological relevance of the results
should be considered first. Statistical methods may be used as an aid in evaluating the test results
.1) Statistical significance should not be the only determining factor for a positive response. Equivocal results should be clarified by further testing
preferably using a modification of experimental conditions.
2). An increase in polyploidy may indicate that the test substance has the potential to induce numerical chromosome aberrations. An increase in
endoreduplication may indicate that the test substance has the potential to inhibit cell cycle progression .
3). A test substance for which the results do not meet the above criteria is considered nonmutagenic in this test.
4). Although most experiments will give clearly positive or negative results, in rare cases the data set will preclude making a definite judgment about the activity of the test substance. Results may remain equivocal or questionable regardless of the number of experiments performed.
5). Positive results from the in vivo chromosome aberration test indicate that a substance induces chromosome aberrations in the bone marrow of
the species tested. Negative results indicate that, under the test conditions, the test substance does not induce chromosome aberrations in the bone
marrow of the species tested.
7). The likelihood that the test substance or its metabolites reach the general circulation or specifically the target tissue (e.g., systemic toxicity)
should be discussed. - Statistics:
- Details on statistics not specified in the reports
Positive results were defined by significant differences in the X 2- test.
Results and discussion
Test results
- Sex:
- female
- Genotoxicity:
- positive
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Additional information on results:
- The percentage of aberrant cells reached a maximum level after 6 h and thereafter decreased, but was not down to the control level after 24 h. Sucrose was tested to study whether NaCl-induced CA was due to high osmolarity. No significant result was noted at a dose of 30 mmole/kg
(10.269 g/kg). Sucrose was not soluble in physiological saline at doses greater than 30 mmole/kg.
Any other information on results incl. tables
Dose-response relationships were studied in cells sampled 6 h after intraperitoneal administration of various amounts of NaCl. Compared to the values for the untreated control, a significant difference was noted for the NaCl dose of 40 mmole/kg (2338 mg/kg). The incidence of aberrant
metaphase cells increased proportionally with the dose of NaCl. The time course of aberrant cells was examined 3, 6, 12, 18 and 24 h after treatment with 40 mmole/kg (2338 mg/kg) of NaCl. The percentage of aberrant cells reached a maximum level after 6 h and thereafter decreased,
but was not down to the control level after 24 h.
See the attached word in the attchment section doc ." Table for results" for the details.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): positive
A statistically significant positive result was obtained with 40 mmole/kg NaCl (2338 mg/kg). - Executive summary:
Sodium Chloride was evaluated for the chromosomal abberation test in the rat bone marrow cells. Female Long-Evans rats (a closed colony of
Long-Evans rats outbred from the colony of the Ben May Laboratory for Cancer Research, University of Chicago), aged 4-6 weeks and weighing
50-100 g were used. They were fed a commercial ration of NMF (Oriental Ferment Co., Tokyo) and water ad libitum, and kept at 22 ° C.
10-40 mmole/kg (584.4-2338 mg/kg) of NaCl dissolved in physiological saline.
Rat Bone marrow cells were examined for the chromosimal abberations. At various times after the intraperitoneal administration of the chemicals, the animals were killed for the analysis of chromosome aberrations in metaphase cells of the femur bone marrow cells. The animals were injected with colchicine (0.3 mg dissolved in 0.3 ml of physiological saline) 1 h before sacrifice. Chromosome specimens were prepared from the femur bone marrow by the conventional method (Sugiyama, 1971), stained in 2% Giemsa solution (pH 6.8) for 15 rain, and analyzed microscopically under blind code. Chromosome aberrations (CA) defining aberrant metaphase cells consisted of breaks and gaps, and all breaks were of the chromatid type.
gaps were not included in the category of damaged cells.
About 150-200 metaphase cells were examined per rat and the percent aberrant metaphase cells was calculated. Each group consisted of 5 rats. Positive results were defined by significant differences in the X 2- test.
Dose-response relationships were studied in cells sampled 6 h after intraperitoneal administration of various amounts of NaCl. Compared to
the values for the untreated control, a significant difference was noted for the NaCl dose of 40 mmole/kg (2338 mg/kg). The incidence of aberrant
metaphase cells increased proportionally with the dose of NaCl. The time course of aberrant cells was examined 3, 6, 12, 18 and 24 h
after treatment with 40 mmole/kg (2338 mg/kg) of NaCl.
The percentage of aberrant cells reached a maximum level after 6 h and thereafter decreased, but was not down to the control level after 24 h. Sucrose was tested to study whether NaCl-induced CA was due to high osmolarity. No significant result was noted at a dose of 30 mmole/kg
(10.269 g/kg). Sucrose was not soluble in physiological saline at doses greater than 30 mmole/kg.
Based on the results of the study the A statistically significant positive result was obtained with 40 mmole/kg NaC1 (2338 mg/kg).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.